Discordance in HIV-1 Co-receptor use prediction by different genotypic algorithms and phenotype assay: Intermediate profile in relation to concordant predictions

Journal of Medical Virology

Volumn 84, Issue 3, 2012, Pages 402-413

  Trabaud, Mary Anne ^a   Icard, Vinca ^a   Scholtes, Caroline ^a,b   Perpoint, Thomas ^a   Koffi, Joseph ^a   Cotte, Laurent ^a   Makhloufi, Djamila ^c   Tardy, Jean Claude ^a   André, Patrice ^a,b  

^a CROIX ROUSSE HOSPITAL   (France)

^b University Lyon i   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Geno2pheno; PSSM; Trofile; Tropism

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC ALGORITHM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; MALE; NONHUMAN; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROTEIN DOMAIN; QUANTITATIVE ANALYSIS; VIRAL TROPISM; VIRUS STRAIN;

ALGORITHMS; COMPUTATIONAL BIOLOGY; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PHENOTYPE; RECEPTORS, CCR5; RECEPTORS, CXCR4; VIRAL TROPISM;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84855863601     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23209     Document Type: Article

References (48)

1. Berger EA, Murphy P, Farber JM. 1999. Chemokine receptors as HIV coreceptors: Roles in viral entry, tropism, and disease. Ann Rev Immunol 17: 657-700.
2. Bozek K, Thielen A, Sierra S, Kaiser R, Lengauer T. 2009. V3 loop sequence space analysis suggests different evolutionary patterns of CCR5- and CXCR4-tropic HIV. PLoS ONE 4: e7387.
3. Chueca N, Garrido C, Alvarez M, Poveda E, de Dios L, Zahonero N, Hernandez-Quero J, Soriano V, Maroto C, de Mendoza C, Garcia F. 2009. Improvement in the determination of HIV tropism using the V3 gene sequence and a combination of bioinformatic tools. J Med Virol 81: 763-7767.
4. Coakley E, Reeves J, Huang W, Mangas-Ruiz M, Maurer I, Harskamp AM, Gupta S, Lie Y, Petropoulos CJ, Schuitemaker H, van't Wout A. 2009. Comparison of human immunodeficiency virus type 1 tropism profiles in clinical samples by the trofile and MT-2 assays. Antimicrob Agents Chemother 53: 4686-4693.
5. Coetzer M, Nedellec R, Salkowitz J, McLaughlin S, Liu Y, Heath L, Mullins JI, Mosier DE. 2008. Evolution of CCR5 use before and during coreceptor switching. J Virol 82: 11758-11766.
6. de Mendoza C, Van Baelen K, Poveda E, Rondelez E, Zahonero N, Stuyver L, Garrido C, Villacian J, Soriano V. 2008. Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent seroconverters. J Acquir Immune Defic Syndr 48: 241-244.
7. Etemad B, Fellows A, Kwambana B, Kamat A, Feng Y, Lee S, Sagar M. 2009. Human immunodeficiency virus type 1 V1-to-V5 envelope variants from the chronic phase of infection use CCR5 and fuse more efficiently than those from early after infection. J Virol 83: 9694-9708.
8. Fernandez G, Llano A, Esgleas M, Clotet B, Esté JA, Martinez MA. 2006. Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncitium-inducing, CXCR4-tropic viruses. J Gen Virol 87: 1285-1294.
9. Garrido C, Roulet V, Chueca N, Poveda E, Aguilera A, Skrabal K, Zahonero N, Carlos S, Garcia F, Faudon J-L, Soriano V, de Mendoza C. 2008. Evaluation of eight different bioinformatics tools to predict viral tropism in differnt human immunodeficiency virus type 1 subtypes. J Clin Microbiol 46: 887-891.
10. Harrigan PR, McGovern R, Dong WWY, Mo T, Zhong X, Chapman D, Lewis M, Thielen A, Jensen M, Valdez H, Heera J, MOTIVATE Tropism Study Group. 2009. Optimization of clinically relevant cut-points for the determination of HIV co-receptor usage to predict maraviroc responses in treatment-experienced (TE) patients using population V3 genotyping. HIV Med 10: 71.
11. Hosoya N, Su Z, Wilkin T, Gulick RM, Flexner C, Hugues MD, Skolnik PR, Giguel F, Greaves WL, Coakley E, Kuritzkes DR. 2009. Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions. J Clin Microbiol 47: 2604-2606.
12. Huang W, Eshelman S, Toma J, Fransen S, Stawiski E, Paxinos EE, Whitcomb JM, Young AM, Donnel D, Mmiro F, Musoke P, Guay LA, Jackson JB, Parkin NT, Petropoulos CJ. 2007. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: High prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol 81: 7885-7893.
13. Jensen MA, Li FS, Van't Wout AB, Nickle DC, Shriner D, He HX, McLaughlin S, Shankarappa R, Margolick JB, Mullins JI. 2003. Improved coreceptor usage prediction and genotyping monitoring of R5-to-X4 transition by motif analysis of human immunodeficency virus type 1env V3 loop sequences. J Virol 77: 13376-13388.
14. Loftin LM, Kienzle M, Yi Y, Lee B, Lee FH, Gray L, Gorry PR, Collman RG. 2010. Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: Efficacy of ENV-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry. Virology 402: 135-148.
15. Low AJ, Dong WWY, Chan D, Sing T, Swanstrom R, Jensen M, Pillai S, Good B, Harrigan PR. 2007. Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates. AIDS 21: F17-F24.
16. Low A, Marchant D, Brumme CJ, Brumme ZL, Dong WWY, Sing T, Hogg RS, Montaner JSG, Gill V, Cheung PK, Harrigan PR. 2008. CD4-dependant characteristics of coreceptor use and HIV type 1 V3 sequence in a large population of therapy-naive individuals. AIDS Res Hum Retroviruses 24: 219-228.
17. Mild M, Kvist A, Esbjörnsson J, Karlsson I, Fenyö EM, Medstrand P. 2010. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-& populations during infection. Infect Genet Evol 10: 356-364.
18. Moore JP, Kitchen S, Pugah P, Zach JA. 2004. The CCR5 and CXCR4 coreceptors-Central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 20: 111-126.
19. Moyle GJ, Wildfire A, Mandalia S, Mayer H, Goodrich J, Whitcomb J, Gazzard BG. 2005. Epidemiology and predictive factors for chemakine receptor use in HIV-1 infection. J Infect Dis 191: 866-872.
20. Olivieri K, Scoggins R, Bor YC, Matthews A, Mark D, Taylor JR, Jr., Chernauskas D, Hammarskjöld M-L, Rekosh D, Camerini D. 2007. The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1. Virology 358: 23-38.
21. Pastore C, Nedellec R, Ramos A, Hartley O, Miamidian JL, Reeves JD, Mosier DE. 2007. Conserved change in envelope function during human immunodeficiency virus type 1 coreceptor switching. J Virol 81: 8165-8179.
22. Pillai S, Good B, Richman D, Corbeil J. 2003. A new perspective on V3 phenotype prediction. AIDS Res Hum Retroviruses 19: 145-149.
23. Poveda E, Briz V, Roulet V, del Mar Gonzalez M, Faudon JL, Soriano V. 2007. Correlation between a phenotypic assay and 3 bioinformatic tools for determining HIV co-receptor use. AIDS 21: 1487-1490.
24. Poveda E, Seclén E, del Mar Gonzälez M, Garcia F, Chueca N, Aguilera A, Rodriguez JJ, Gonzalez-Lahoz J, Soriano V. 2009. Design and validation of new genotypic tools for easy and reliable estimation of HIV tropsim before using CCR5 antogonists. J Antimicrob Chemother 63: 1006-1010.
25. Prosperi MCF, Bracciale L, Fabbiani M, Di Giambenedetto S, Razzolini F, Meini G, Colafigli M, Marzocchetti A, Cauda R, Zazzi M, De Luca A. 2010. Comparative determination of HIV-1 co-receptor tropism by enhanced sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping. Retrovirology 7: 56.
26. Raymond S, Delobel P, Mavigner M, Cazabat M, Souyris C, Sandres-Sauné Cuzin L, Marchou B, Massip P, Izopet J. 2008. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism. AIDS 22: F11-F16.
27. Raymond S, Delobel P, Mavigner M, Cazabat M, Souyris C, Encinas S, Sandres-Sauné K, Pasquier C, Marchou B, Massip P, Izopet J. 2009. Genotypic prediction of human immunodeficiency virus type 1 CRF02-AG tropism. J Clin Microbiol 47: 2292-2294.
28. Recordon-Pinson P, Soulié C, Flandre P, Descamps D, Lazrek M, Charpentier C, Montes B, Trabaud MA, Cottalorda J, Schneider V, Morand-Joubert L, Tamalet C, Desbois D, Macé M, Ferré V, Vabret A, Ruffault A, Pallier C, Raymond S, Izopet J, Reynes J, Marcellin AG, Masquelier B, the ANRS AC11 Resistance Study Group. 2010. Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: The ANRS GenoTropism study. Antimicrob Agents Chemother 54: 3335-3340.
29. Repits J, Sterjovski J, Badia-Martinez D, Mild M, Gray L, Churchill MJ, Purcell DFJ, Karlsson A, Albert J, Fenyö EM, Achour A, Gorry PR, Jansson M. 2008. Primary HIV-1 R5 isolates from end-stage disease display enhanced fitness in parallel with increased gp120 net charge. Virology 379: 125-134.
30. Saliou A, Delobel P, Dubois M, Nicot F, Raymond S, Calvez V, Masquelier B, Izopet J, the ANRS AC11 Resistance Study Group. 2011. Concordance between two phenotypic assays and ultra deep pyrosequencing for determining HIV-1 tropism. Antimicrob Agents Chemother 55: 2831-2836.
31. Sanchez V, Masia M, Robledano C, Padilla S, Ramos JM, Gutierrez F. 2010. Performance of genotypic algorithms for predicting HIV-1 tropims measured against the enhanced-sensitivity Trofile coreceptor tropism assay. J Clin Microbiol 48: 4135-4139.
32. Saracino A, Monno L, Punzi G, Cibelli DC, Tartaglia A, Scudeller L, Brindicci G, Lagioia A, Scotto G, Angarano G. 2007. HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples. Virus Res 130: 34-42.
33. Seclén E, Garrido C, del Mar Gonzalez M, Gonzalez-Lahoz J, de Mendoza C, Soriano V, Poveda E. 2010. High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists. J Antimicrob Chemother 65: 1486-1492.
34. Sing T, Low A, Beerenwinkel N, Sander O, Cheung PK, Domingues FS, Büch J, Daümer M, Kaiser R, Lengauer T, Harrigan PR. 2007. Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antivir ther 12: 1097-1106.
35. Skrabal K, Low A, Dong WWY, Sing T, Cheung PK, Mammano F, Harrigan PR. 2007. Determining Human Immunodeficiency virus coreceptor use in a clinical setting: Degree of correlation between two phenotypic assays and a bioinformatic model. J Virol 45: 279-284.
36. Soulié C, Derache A, Aimé C, Marcellin AG, Carcelin G, Simon A, Katlama C, Calvez V. 2008. Comparaison of two genotypic algorithms to determine HIV-1 tropism. HIV Med 9: 1-5.
37. Svicher V, D'Arrigo R, Alteri C, Andreoni M, Angarano G, Antinori A, Antonelli G, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bonn I, Bruzzone B, Callegaro AP, Cammarota R, Canducci F, Ceccherini-Silberstein F, Clementi M, Monforte AD, De Luca A, Di Biagio A, Di Gianbenedetto S, Di Perri G, Di Pietro M, Fabeni L, Fadda G, Galli M, Gennari W, Ghisetti V, Giacometti A, Gori A, Leoncini F, Maggiolo F, Maserati R, Mazzotta F, Micheli V, Meini G, Monno L, Mussini C, Nozza S, Paolucci S, Parisi S, Pecorari M, Pizzi D, Quirino T, Re MC, Rizzardini G, Santangelo R, Soria A, Stazi F, Sterrantino G, Turriziani O, Viscoli C, Vullo V, Lazzarin A, Perno CF, OSCAR Study Group. 2010. Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay/results from the OSCAR Study Group. New Microbiol 33: 195-206.
38. Svicher V, Balestra E, Cento V, Sarmati L, Dori L, Vandenbroucke I, D'Arrigo R, Buonomini AR, Van Marck H, Surdo M, Saccomandi P, Mostmans W, Aerssens J, Aquaro S, Stuyver LJ, Andreoni M, Ceccherini-Silberstein F, Perno CF. 2011. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro. Antiviral res 90: 42-53.
39. Swenson LC, Moores A, Low AJ, Thielen A, Dong WWY, Woods C, Jensen MA, Wynhoven B, Chan D, Glascock C, Harrigan PR. 2010. Improved detection of CXCR4-using HIV by V3 genotyping: Application of population-based and "deep" sequencing to plasma RNA and proviral DNA. J Acquir ImmuneDefic Syndr 54: 506-510.
40. Swenson LC, Mo T, Dong WWY, Zhong X, Woods CK, Jensen MA, Thielen A, Chapman D, Lewis M, James I, Heera J, Valdez H, Harrigan PR. 2011. Deep sequencing to infer HIV-1 Co-receptor usage: Application to three clinical trials of Maraviroc in treatment-experienced patients. J Infec Dis 203: 237-245.
41. Team R Development Core. 2010. R: A language and environment for statistical computing. Vienna, Austria: Team R Development Core.
42. Toma J, Whitcomb JM, Petropoulos CJ, Huang W. 2010. Dual-tropic HIV type1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors. AIDS 24: 2181-2186.
43. Vandekerckhove L, Verhofstede C, Demecheleer E, De Wit S, Florence E, Fransen K, Moutschen M, Mostmans W, Kabeya K, Mackie N, Plum J, Vaira D, Van Baelen K, Vandenbroucke I, Van Eygen V, Van Marck H, Vogelaers D, Geretti AM, Stuyver LJ. 2011a. Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment. J Antimicrob Chemother 66: 265-272.
44. Vandekerckhove LP, Wensing AM, Kaiser R, Brun-Vézinet F, Clotet B, De Luca A, Dressler S, Garcia F, Geretti AM, Klimkait T, Korn K, Masquelier B, Perno CF, Schapiro JM, Soriano V, Sönnerborg A, Vandamme AM, Verhofstede C, Walter H, Zazzi M, Boucher CA, European Consensus Group on Clinical Management of Tropism Testing. 2011b. European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis 11: 394-407.
45. Vandenbroucke I, Van Eygen V, Rondelez E, Vermeiren H, Van Baelen K. 2008. Minor detection at different template concentrations in HIV-1 phenotypic and genotypic tropism testing. Open Virol J 2: 8-14.
46. Vandenbroucke I, Van Marck H, Mostmans W, Van Eygen V, Rondelez E, Thys K, Van Baelen K, Fransen K, Vaira D, Kabeya K, De Wit S, Florence E, Moutschen M, Vandekerckhove L, Verhofstede C, Stuyver LJ. 2010. HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays. AIDS Res Ther 7: 4.
47. Weber J, Piontkivska H, Quinones-Mateu ME. 2006. HIV type 1 tropism and inhibitors of viral entry: Clinical implications. AIDS Rev 8: 60-77.
48. Whitcomb JM, Huang W, Fransen S, Limoli K, Toma J, Wrin T, Chappey C, Kiss LDB, Paxinos EE, Petropoulos CJ. 2007. Development and characterization of a novel single-cycle recombiant virus assay to determine human immunodeficiency virus type 1 coreceptor tropism. Antimicrob Agents Chemother 51: 566-577.